TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16959618

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily from a dry powder inhaler (HandiHaler)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Ipratropium 20 microg four times daily from a metered dose inhaler
Number of subjects: 132
Study: 15221622

Group type: EXPERIMENTAL
Intervention: Co-administration of CR L-dopa and entacapone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Delayed administration of entacapone (30 and 90 minutes) with CR L-dopa
Number of subjects: 10
Study: 11299402

Group type: EXPERIMENTAL
Intervention: Lateral sphincterotomy under local anesthesia (topical anesthetic cream xylocaine 2% and local anesthesia)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Lateral sphincterotomy under general anesthesia
Number of subjects: 62
Study: 9390597

Group type: EXPERIMENTAL
Intervention: Ketamine 1 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental 4 mg/kg
Number of subjects: 40
Study: 8433253

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration with tetracycline root conditioning (100 mg/ml)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Guided tissue regeneration with membrane alone (control)
Number of subjects: 18
Study: 3677365

Group type: EXPERIMENTAL
Intervention: Graded symptom-limited bicycle exercise testing
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Ambulatory electrocardiographic monitoring
Number of subjects: 607
Study: 30558607

Group type: EXPERIMENTAL
Intervention: Per oral (p.o.) antibiotic monotherapy
Number of subjects: 552

Group type: COMPARATOR
Intervention: Intravenous (i.v.) antibiotic therapy followed by p.o. antibiotics
Number of subjects: 552
Study: 26809111

Group type: EXPERIMENTAL
Intervention: DEB-TACE plus sorafenib 400 mg twice daily
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo plus DEB-TACE
Number of subjects: 307
Study: 24997825

Group type: EXPERIMENTAL
Intervention: Liposome-paclitaxel plus carboplatin (LPC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Paclitaxel plus carboplatin (PC)
Number of subjects: 54
Study: 22848896

Group type: EXPERIMENTAL
Intervention: Inward-inclined platform implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional external-hexagon implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (external-hexagon implants)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Test group (inward-inclined platform implants)
Number of subjects: 40
Study: 20694297

Group type: EXPERIMENTAL
Intervention: Soybean protein formula
Number of subjects: 50

Group type: COMPARATOR
Intervention: Casein protein formula
Number of subjects: 50
Study: 17287681

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES) technology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailor-made strategy for each patient
Number of subjects: 0
Study: 15762389

Group type: EXPERIMENTAL
Intervention: Petting a live dog (Group 1)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Petting a stuffed dog (Group 2)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sitting comfortably on a couch (Group 3)
Number of subjects: 55
Study: 11173127

Group type: EXPERIMENTAL
Intervention: Translational research in radiation oncology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Translational process
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future improvements in therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Investment in translational network
Number of subjects: 0
Study: 9760352

Group type: EXPERIMENTAL
Intervention: Protein-carbohydrate supplement
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8169567

Group type: EXPERIMENTAL
Intervention: Caffeine (178 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2851414

Group type: EXPERIMENTAL
Intervention: 5 mg ramipril
Number of subjects: 174

Group type: COMPARATOR
Intervention: 10 mg enalapril
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: ramipril
Number of subjects: 174

Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 174
Study: 28229502

Group type: EXPERIMENTAL
Intervention: Parent singing exposure to novel play songs
Number of subjects: 64

Group type: COMPARATOR
Intervention: Musical toy exposure to novel play songs
Number of subjects: 64
Study: 26481174

Group type: EXPERIMENTAL
Intervention: NAVIGATE (comprehensive, multidisciplinary, team-based treatment)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Community care (usual care)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: NAVIGATE (for participants with duration of untreated psychosis <74 weeks)
Number of subjects: 404

Group type: COMPARATOR
Intervention: NAVIGATE and Community care
Number of subjects: 404
Study: 24168107

Group type: EXPERIMENTAL
Intervention: High mushroom diet (treatment B)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No mushrooms diet (treatment A)
Number of subjects: 10
Study: 22794203

Group type: EXPERIMENTAL
Intervention: 1-visit endodontic treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2-visit endodontic treatment with calcium hydroxide medication
Number of subjects: 20
Study: 20004464

Group type: COMPARATOR
Intervention: Clinically driven monitoring (CDM)
Number of subjects: 3321

Group type: EXPERIMENTAL
Intervention: Laboratory and clinical monitoring (LCM)
Number of subjects: 3321
Study: 18308905

Group type: EXPERIMENTAL
Intervention: Cognitive enhancement therapy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Baseline foresight measures
Number of subjects: 58
Study: 16051509

Group type: EXPERIMENTAL
Intervention: Modified Brief Pain Inventory short form (BPI-sf) used daily in patients with osteoarthritis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Original Brief Pain Inventory short form (BPI-sf)
Number of subjects: 0
Study: 14977302

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite
Number of subjects: 20
Study: 11305520

Group type: EXPERIMENTAL
Intervention: Torsemide 20 mg/day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Frusemide 40 mg/day
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both interventions (Torsemide and Frusemide)
Number of subjects: 46
Study: 9561978

Group type: EXPERIMENTAL
Intervention: Combined modality therapy including radiotherapy (16 patients) and sequential and intraventricular chemotherapy (methotrexate in 32 patients; cytarabine in 16; thiotepa in 6). Concurrent systemic chemotherapy was given to 12 patients.
Number of subjects: 32
Study: 7942676

Group type: EXPERIMENTAL
Intervention: Bipolar system (Bitome)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Monopolar system
Number of subjects: 100
Study: 3065507

Group type: EXPERIMENTAL
Intervention: Sustained release verapamil (Securon SR, Knoll)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long acting propranolol (Inderal LA, ICI)
Number of subjects: 0
Study: 30474107

Group type: EXPERIMENTAL
Intervention: Feedback with explanation
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Feedback without explanation
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: No feedback
Number of subjects: 106

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 106
Study: 29104103

Group type: EXPERIMENTAL
Intervention: Vitamin D (400-4800 IU/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 28513877

Group type: EXPERIMENTAL
Intervention: Sinus rhythm with heart rate increase
Number of subjects: 2539

Group type: EXPERIMENTAL
Intervention: Sinus rhythm in the highest heart rate quartile (>90 bpm)
Number of subjects: 2539

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) with heart rate increase
Number of subjects: 2539

Group type: COMPARATOR
Intervention: Bisoprolol allocation
Number of subjects: 2539
Study: 26283758

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study: 23265707

Group type: EXPERIMENTAL
Intervention: MBSR + usual care
Number of subjects: 336

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 336
Study: 22003288

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg once daily
Number of subjects: 1648

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1648
Study: 18584198

Group type: EXPERIMENTAL
Intervention: Synacthen (0.25 mg, TX)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study: 17310820

Group type: EXPERIMENTAL
Intervention: On‐3TC
Number of subjects: 131

Group type: COMPARATOR
Intervention: Off‐3TC
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Viruses containing M1841/V
Number of subjects: 131
Study: 12691395

Group type: EXPERIMENTAL
Intervention: EVD catheters impregnated with minocycline and rifampin
Number of subjects: 288

Group type: COMPARATOR
Intervention: Standard untreated EVD catheters (control)
Number of subjects: 288
Study: 10735892

Group type: EXPERIMENTAL
Intervention: Cisplatin 50 mg/m(2), gemcitabine 1,000 mg/m(2), and vinorelbine 25 mg/m(2) on days 1 and 8 every 3 weeks (PGV)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Cisplatin 100 mg/m(2) on day 1 and gemcitabine 1,000 mg/m(2) on days 1, 8, and 15 every 4 weeks (PG)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Cisplatin 120 mg/m(2) on days 1 and 29 and vinorelbine 30 mg/m(2)/wk (PV)
Number of subjects: 180
Study: 9199002

Group type: EXPERIMENTAL
Intervention: Frequency questionnaire
Number of subjects: 493

Group type: COMPARATOR
Intervention: Dietary interview
Number of subjects: 493
Study: 1389513

Group type: EXPERIMENTAL
Intervention: 20 mg tamoxifen per day for 2 years
Number of subjects: 82

Group type: COMPARATOR
Intervention: no drug treatment
Number of subjects: 82
Study: 2932205

Group type: EXPERIMENTAL
Intervention: Ketanserin (serotonin antagonist) for 3 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control period (no medication for 3 days)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ergonovine administered in incremental doses (0.0125 mg to 0.4 mg)
Number of subjects: 6
Study: 18320439

Group type: EXPERIMENTAL
Intervention: GnRH-a (triptorelin 0.1 mg on the day of ovum pickup, on the day of embryo transfer, and three days thereafter)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30399363

Group type: EXPERIMENTAL
Intervention: Post-compression reactive hyperemia (PCRH) with 1- to 4-min pressure applications of 16 to 34 kPa
Number of subjects: 15

Group type: COMPARATOR
Intervention: Post-occlusive reactive hyperemia (PORH) with 3-min forearm cuff occlusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PCRH
Number of subjects: 15

Group type: COMPARATOR
Intervention: PORH
Number of subjects: 15
Study: 28137537

Group type: EXPERIMENTAL
Intervention: Peritoneal Resuscitation (PR)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Conventional Resuscitation (CR)
Number of subjects: 103
Study: 25853876

Group type: EXPERIMENTAL
Intervention: 1 d/wk training (G1; N=21)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 2 d/wk training (G2; N=27)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 3 d/wk training (G3; N=23)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (CG; N=47)
Number of subjects: 118
Study: 24044802

Group type: EXPERIMENTAL
Intervention: Partial breast irradiation (PBI) using interstitial multi-catheter high-dose-rate brachytherapy (4 Gy, twice a day for 4 days, until 32 Gy)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Partial breast irradiation (PBI) using interstitial multi-catheter high-dose-rate brachytherapy
Number of subjects: 100
Study: 22053942

Group type: EXPERIMENTAL
Intervention: Hypericum perforatum 900-1,500 mg/d
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Sertraline 50-100 mg/d
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 19519236

Group type: EXPERIMENTAL
Intervention: Facilitator only intervention
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Computer and facilitator intervention
Number of subjects: 77

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 77
Study: 16773482

Group type: EXPERIMENTAL
Intervention: Psychoanalytically oriented psychotherapy lasting for six weeks
Number of subjects: 20
Study: 15376564

Group type: EXPERIMENTAL
Intervention: Endoscopic therapy plus octreotide 50 microg/h bolus and continuous infusion for 5 days (n=36)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Octreotide 50 microg/h bolus and continuous infusion for 5 days (n=13)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Endoscopic therapy only (banding and/or sclerotherapy) (n=43)
Number of subjects: 92
Study: 11783824

Group type: EXPERIMENTAL
Intervention: Multimodal biopsychosocial treatments including cognitive-behavioral and/or behavioral components
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Electromyogram feedback
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Other interventions (unspecified)
Number of subjects: 21
Study: 9338537

Group type: EXPERIMENTAL
Intervention: Combination of terfenadine (120 mg) and ranitidine (300 mg)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Terfenadine alone (120 mg)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Combination of terfenadine and ranitidine
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Terfenadine alone
Number of subjects: 121
Study: 8177984

Group type: EXPERIMENTAL
Intervention: Repeated measurements of covariates
Number of subjects: 0
Study: 3108622

Group type: EXPERIMENTAL
Intervention: Continuous nasoenteric formula infusion
Number of subjects: 4

Group type: COMPARATOR
Intervention: Intermittent nasoenteric formula infusion
Number of subjects: 4
Study: 31866373

Group type: EXPERIMENTAL
Intervention: Hallux valgus group (HVA >20°, IMA >9°)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group (HVA <15°, IMA <9°)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 213
Study: 30843450

Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg/day
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Vortioxetine 20 mg/day
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study: 29070467

Group type: EXPERIMENTAL
Intervention: Endoscopic surgery (group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Open surgery (group B)
Number of subjects: 80
Study: 26324315

Group type: EXPERIMENTAL
Intervention: Bedoradrine (1200 μg)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 23993034

Group type: EXPERIMENTAL
Intervention: Direct current electrical stimulation
Number of subjects: 1381

Group type: EXPERIMENTAL
Intervention: Capacitive coupling (CC) electrical stimulation
Number of subjects: 1381

Group type: EXPERIMENTAL
Intervention: Inductive coupling electrical stimulation
Number of subjects: 1381
Study: 22254404

Group type: EXPERIMENTAL
Intervention: FES-induced cycling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive cycling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal cycling (able-bodied controls)
Number of subjects: 0
Study: 19853695

Group type: EXPERIMENTAL
Intervention: AE + IMT
Number of subjects: 24

Group type: COMPARATOR
Intervention: AE
Number of subjects: 24
Study: 16702490

Group type: COMPARATOR
Intervention: 4 mg perindopril
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 8 mg perindopril
Number of subjects: 57
Study: 15381507

Group type: EXPERIMENTAL
Intervention: Multifactorial falls prevention programme including 3 months gait and balance training, medication review, podiatry and optometry
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 196
Study: 12934982

Group type: EXPERIMENTAL
Intervention: Citalopram (mean dose of 57.9 mg/day)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 10220007

Group type: EXPERIMENTAL
Intervention: Executive dysfunction
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Disinhibition of responses
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Motor dyscoordination
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Executive and motor deficits
Number of subjects: 26
Study: 7540231

Group type: EXPERIMENTAL
Intervention: Fresenius MTS C (Cuprophane)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hospal AN 69 (Polyacrylonitrile)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CP capillaries
Number of subjects: 0

Group type: COMPARATOR
Intervention: PA membranes
Number of subjects: 0
Study: 2371424

Group type: EXPERIMENTAL
Intervention: High dose inhaled therapy (salbutamol and beclomethasone dipropionate)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Combination of inhaled steroids and beta agonist
Number of subjects: 160
Study: 665977

Group type: EXPERIMENTAL
Intervention: 18-gauge polypropylene cannula
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: 20-gauge Teflon cannula
Number of subjects: 148
Study: 31635907

Group type: EXPERIMENTAL
Intervention: Locking plates (VariAx™ - StrykerⓇ)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-locking plates (VIVES™ - StrykerⓇ)
Number of subjects: 105
Study: 27353449

Group type: EXPERIMENTAL
Intervention: PriCARE
Number of subjects: 120
Study: 26725291

Group type: EXPERIMENTAL
Intervention: Telepsychiatry (N=20)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control (In-person psychiatric sessions, N=40)
Number of subjects: 71
Study: 24460668

Group type: EXPERIMENTAL
Intervention: CLP 7.5 g/day
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CLP 15.0 g/day
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CLP 25.0 g/day
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CLP 15.0 g/day under fasting conditions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (untreated cohort)
Number of subjects: 25
Study: 21499182

Group type: EXPERIMENTAL
Intervention: Cooling with temperatures <32.0°C during induction (n = 33)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cooling with temperatures <32.0°C during maintenance (n = 10)
Number of subjects: 101

Group type: COMPARATOR
Intervention: All other cooled infants (n = 58)
Number of subjects: 101
Study: 19932775

Group type: EXPERIMENTAL
Intervention: Combination lipid therapy
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: LDL cholesterol-lowering and HDL cholesterol-increasing therapies
Number of subjects: 445
Study: 17241666

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.4 mg/ml) eyedrops, 1 drop 4 times a day for 3 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo, 1 drop 4 times a day for 3 weeks
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.4 mg/ml) eyedrops
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 15717519

Group type: EXPERIMENTAL
Intervention: 6% HES solution, 5-6 ml/kg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 6% HES solution, 5-6 ml/kg and 1.5% reamberin solution, 5 ml/kg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Physiological single pregnancy (control group)
Number of subjects: 42
Study: 12092991

Group type: EXPERIMENTAL
Intervention: Fuji Bond LC (FBLC) resin‐modified glass‐ionomer bonding system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FBLC with light-curing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FBLC without light-curing (co-curing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advanced fluorescent imaging of FBLC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of HEMA in the matrix of FBLC
Number of subjects: 0
Study: 9817522

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg twice daily
Number of subjects: 619

Group type: COMPARATOR
Intervention: Ceftriaxone 4 g i.v. once daily
Number of subjects: 619
Study: 7711691

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 129

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both laparoscopic and open surgery
Number of subjects: 129
Study: 29672731

Group type: EXPERIMENTAL
Intervention: Adjunct AF surgery (ablation)
Number of subjects: 352
Study: 26455498

Group type: EXPERIMENTAL
Intervention: Telephone genetic counseling (TC)
Number of subjects: 554

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 554
Study: 24929927

Group type: EXPERIMENTAL
Intervention: Self-compassion
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waiting condition
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reappraisal
Number of subjects: 48

Group type: COMPARATOR
Intervention: Acceptance
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Self-compassion and Reappraisal
Number of subjects: 48
Study: 23750991

Group type: EXPERIMENTAL
Intervention: Biannual ultrasonography
Number of subjects: 163

Group type: COMPARATOR
Intervention: Yearly CT
Number of subjects: 163
Study: 19881394

Group type: EXPERIMENTAL
Intervention: Nutrient-enriched formula without extra energy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 102

Group type: COMPARATOR
Intervention: Unfortified human milk
Number of subjects: 102
Study: 18676384

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine (15 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.75% levobupivacaine (15 mg)
Number of subjects: 60
Study: 16537671

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment for 3 months
Number of subjects: 10
Study: 14518700

Group type: EXPERIMENTAL
Intervention: Indinavir/ritonavir 800/100 mg with food
Number of subjects: 9

Group type: COMPARATOR
Intervention: Indinavir/ritonavir 800/100 mg on an empty stomach
Number of subjects: 9
Study: 10740135

Group type: EXPERIMENTAL
Intervention: Lamifiban bolus and infusion
Number of subjects: 5228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5228
Study: 8922765

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (perimenstrual group)
Number of subjects: 85
Study: 1558466

Group type: EXPERIMENTAL
Intervention: Half-dose maintenance of imipramine for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acute-phase treatment with imipramine
Number of subjects: 0